Wikidata

(Q46432503)

English

Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.

scientific article published in April 2005

In more languages
default for all languages
No label defined

No description defined

Statements

title
Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15823673
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15823673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46432503&oldid=1095189495"